Koyfin Home > Directory > Health Care > Antares Pharma > Cash Flow from Operations

Antares Pharma Cash Flow from Operations Chart (ATRS)

Antares Pharma annual/quarterly Cash Flow from Operations from 2000 to 2018. Cash flow from operating activities (CFO) is an accounting item that indicates the amount of money a company brings in from ongoing, regular business activities, such as manufacturing and selling goods or providing a service. Cash flow from operating activities does not include long-term capital or investment costs.
  • Antares Pharma Cash Flow from Operations for the quarter ending September 09, 2018 was $0m a -9,658.63% increase of 8m year over year
  • Antares Pharma Cash Flow from Operations for the last 12 months ending September 09, 2018 was $-18m a -29.95% increase of 5m year over year
  • Antares Pharma Annual Cash Flow from Operations for 2017 was $-23m a 34.20% decrease of -8m from 2016
  • Antares Pharma Annual Cash Flow from Operations for 2016 was $-15m a -85.58% increase of 13m from 2015
  • Antares Pharma Annual Cash Flow from Operations for 2015 was $-28m a 6.62% decrease of -2m from 2014
Other Cash Flow Metrics:
  • Antares Pharma Levered Free Cash Flow (FCF) for the quarter ending September 09, 2018 was $0m a -10,730.73% increase of 6m year over year
  • Antares Pharma Total Revenue for the quarter ending December 12, 2018 was $19m a 32.51% increase of 6m year over year
View Chart On Koyfin

Quarterly ATRS Cash Flow from Operations Data

09/2018$0m
06/2018$-4m
03/2018$-6m
12/2017$-8m
09/2017$-5m
06/2017$-6m
03/2017$-4m
12/2016$-3m
09/2016$-3m
06/2016$-5m

Annual ATRS Cash Flow from Operations Data

2017$-23m
2016$-15m
2015$-28m
2014$-26m
2013$-15m
2012$-10m
2011$-2m
2010$-6m
2009$-5m
2008$-10m